CHGCF
Price
$42.25
Change
-$2.55 (-5.69%)
Updated
Jan 17 closing price
Capitalization
49.42B
GIFOF
Price
$6.98
Change
-$1.30 (-15.70%)
Updated
Dec 30 closing price
Capitalization
8.78B
Ad is loading...

CHGCF vs GIFOF

Header iconCHGCF vs GIFOF Comparison
Open Charts CHGCF vs GIFOFBanner chart's image
Chugai Pharmaceutical
Price$42.25
Change-$2.55 (-5.69%)
Volume$6.72K
Capitalization49.42B
Grifols Sa
Price$6.98
Change-$1.30 (-15.70%)
Volume$150
Capitalization8.78B
CHGCF vs GIFOF Comparison Chart
Loading...
CHGCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GIFOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CHGCF vs. GIFOF commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHGCF is a Hold and GIFOF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (CHGCF: $42.25 vs. GIFOF: $6.98)
Brand notoriety: CHGCF and GIFOF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: CHGCF: 84% vs. GIFOF: 0%
Market capitalization -- CHGCF: $49.42B vs. GIFOF: $8.78B
CHGCF [@Pharmaceuticals: Major] is valued at $49.42B. GIFOF’s [@Pharmaceuticals: Major] market capitalization is $8.78B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHGCF’s FA Score shows that 1 FA rating(s) are green whileGIFOF’s FA Score has 1 green FA rating(s).

  • CHGCF’s FA Score: 1 green, 4 red.
  • GIFOF’s FA Score: 1 green, 4 red.
According to our system of comparison, CHGCF is a better buy in the long-term than GIFOF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHGCF’s TA Score shows that 2 TA indicator(s) are bullish while GIFOF’s TA Score has 0 bullish TA indicator(s).

  • CHGCF’s TA Score: 2 bullish, 4 bearish.
  • GIFOF’s TA Score: 0 bullish, 3 bearish.
According to our system of comparison, CHGCF is a better buy in the short-term than GIFOF.

Price Growth

CHGCF (@Pharmaceuticals: Major) experienced а -5.33% price change this week, while GIFOF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.03%. For the same industry, the average monthly price growth was -0.28%, and the average quarterly price growth was -6.86%.

Industries' Descriptions

@Pharmaceuticals: Major (+0.03% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHGCF($49.4B) has a higher market cap than GIFOF($8.79B). GIFOF has higher P/E ratio than CHGCF: GIFOF (48.31) vs CHGCF (20.79). CHGCF YTD gains are higher at: 1.246 vs. GIFOF (0.000). CHGCF has higher annual earnings (EBITDA): 458B vs. GIFOF (726M). CHGCF has more cash in the bank: 665B vs. GIFOF (557M). CHGCF has less debt than GIFOF: CHGCF (215M) vs GIFOF (10.9B). CHGCF has higher revenues than GIFOF: CHGCF (1.24T) vs GIFOF (6.46B).
CHGCFGIFOFCHGCF / GIFOF
Capitalization49.4B8.79B562%
EBITDA458B726M63,085%
Gain YTD1.2460.000-
P/E Ratio20.7948.3143%
Revenue1.24T6.46B19,257%
Total Cash665B557M119,390%
Total Debt215M10.9B2%
FUNDAMENTALS RATINGS
CHGCF vs GIFOF: Fundamental Ratings
CHGCF
GIFOF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
8
Undervalued
PROFIT vs RISK RATING
1..100
44100
SMR RATING
1..100
4387
PRICE GROWTH RATING
1..100
5163
P/E GROWTH RATING
1..100
6597
SEASONALITY SCORE
1..100
65n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GIFOF's Valuation (8) in the null industry is in the same range as CHGCF (33). This means that GIFOF’s stock grew similarly to CHGCF’s over the last 12 months.

CHGCF's Profit vs Risk Rating (44) in the null industry is somewhat better than the same rating for GIFOF (100). This means that CHGCF’s stock grew somewhat faster than GIFOF’s over the last 12 months.

CHGCF's SMR Rating (43) in the null industry is somewhat better than the same rating for GIFOF (87). This means that CHGCF’s stock grew somewhat faster than GIFOF’s over the last 12 months.

CHGCF's Price Growth Rating (51) in the null industry is in the same range as GIFOF (63). This means that CHGCF’s stock grew similarly to GIFOF’s over the last 12 months.

CHGCF's P/E Growth Rating (65) in the null industry is in the same range as GIFOF (97). This means that CHGCF’s stock grew similarly to GIFOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CHGCFGIFOF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
41%
N/A
Momentum
ODDS (%)
Bearish Trend 12 days ago
37%
Bearish Trend 12 days ago
59%
MACD
ODDS (%)
N/A
Bearish Trend 12 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
35%
Bullish Trend 12 days ago
50%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
27%
Bearish Trend 12 days ago
48%
Advances
ODDS (%)
Bullish Trend 17 days ago
27%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
44%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 12 days ago
52%
View a ticker or compare two or three
Ad is loading...
CHGCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GIFOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDBAX46.050.26
+0.57%
Janus Henderson Balanced A
BGCJX14.210.08
+0.55%
Baillie Gifford EAFE Plus All Cap 3
PWDAX9.750.05
+0.52%
Donoghue Forlines Dividend A
MFAIX24.770.06
+0.24%
Morgan Stanley Inst Intl Advtg I
PIUIX21.660.05
+0.23%
Federated Hermes International Equity IS

CHGCF and

Correlation & Price change

A.I.dvisor tells us that CHGCF and CHGCY have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHGCF and CHGCY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHGCF
1D Price
Change %
CHGCF100%
-5.69%
CHGCY - CHGCF
28%
Poorly correlated
+0.52%
DSKYF - CHGCF
13%
Poorly correlated
+5.84%
GIFOF - CHGCF
6%
Poorly correlated
N/A
CHJTF - CHGCF
1%
Poorly correlated
N/A
DSNKY - CHGCF
0%
Poorly correlated
+1.59%
More

GIFOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GIFOF has been loosely correlated with GRFS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GIFOF jumps, then GRFS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GIFOF
1D Price
Change %
GIFOF100%
N/A
GRFS - GIFOF
37%
Loosely correlated
+0.41%
GIFLF - GIFOF
32%
Poorly correlated
N/A
GIKLY - GIFOF
27%
Poorly correlated
+0.61%
AMRN - GIFOF
21%
Poorly correlated
+0.72%
BAYZF - GIFOF
12%
Poorly correlated
+2.59%
More